Highlights
- In connection with the retirement of its Chief Scientific Officer, John
A. Wise, Ph.D., NAI entered into a Consulting Agreement with Dr. Wise
through December 31, 2009.
- NAI repurchased 100,000 shares of its common stock held by its Chairman
and CEO, Mark A. LeDoux, his wife, their family partnership and related
children's trust.
SAN MARCOS, Calif, July 6 /PRNewswire-FirstCall/ -- Natural
Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading
formulator, manufacturer and marketer of customized nutritional
supplements, today announced the retirement of John A. Wise, Ph.D., 67, as
Chief Scientific Officer effective June 30, 2007, and that Dr. Wise has
agreed to continue with NAI as a consultant through December 31, 2009.
Dr. Wise stated, "It has been personally rewarding and gratifying to
participate in and contribute to the significant growth and success of NAI
over the past 20 years. NAI has been an industry leader in applying
evidence-based science to establish the efficacy of our products for
improving health. Our science-based formulas have been widely distributed
throughout the world, resulting in high consumer acceptance and positively
affecting many peoples' lives. I am proud to have been part of this and I
look forward to my continuing relationship and contribution to NAI during
this transition in my career."
CEO Mark Le Doux added, "Dr. Wise has demonstrated true leadership in
the area of nutritional science. His advocacy for research, design and
development of effective dietary supplements exemplifies his dedication to
excellence. Dr. Wise's long tenure at NAI has been the hallmark of our
commitment to quality science underlying our nutritional supplements. We
wish Dr. Wise well in this new phase of his career and are pleased he has
agreed to continue working with NAI and help us continue that commitment."
NAI also announced it has agreed to repurchase 100,000 shares of its
common stock held by its Chairman and CEO, Mark LeDoux, his wife, their
family partnership and related children's trust (together, the "LeDouxs").
The purchase of the shares was approved by the independent members of NAI's
board of directors at their meeting on June 29, 2007, provided NAI was able
to purchase the shares at a 10% discount from the closing price on such
date. The sale of the shares by the LeDouxs has been undertaken for estate
tax reasons related to the death of Mr. LeDoux's mother, a co-founder of
NAI. Given the relatively thin trading market for NAI's stock, the board
determined the repurchase of the shares from the LeDouxs was in the best
interest of NAI and its stockholders, particularly in view of the
discounted price and the potential negative impact of repeated periodic
sales on the open market. The shares to be repurchased represent a
relatively small percentage of the overall shares beneficially owned by Mr.
LeDoux and, following the sale, he will continue to own approximately 18%
of NAI's outstanding shares.
NAI, headquartered in San Marcos, California, is a leading formulator,
manufacturer and marketer of nutritional supplements and provides strategic
partnering services to its customers. Our comprehensive partnership
approach offers a wide range of innovative nutritional products and
services to our clients including: scientific research, clinical studies,
proprietary ingredients, customer-specific nutritional product formulation,
product testing and evaluation, marketing management and support, packaging
and delivery system design, regulatory review and international product
registration assistance. For more information about NAI, please see our
website at http://www.nai-online.com.
This press release contains forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934 that are not
historical facts and information. These statements represent our
intentions, expectations and beliefs concerning future events, including,
among other things, our expectations and beliefs with respect to our future
relationship with Dr. Wise and the success of such relationship, and the
potential impact on our stock price from the repurchase. We wish to caution
readers these statements involve risks and uncertainties that could cause
actual results and outcomes for future periods to differ materially from
any forward-looking statement or views expressed herein. NAI's financial
performance and the forward-looking statements contained herein are further
qualified by other risks including those set forth from time to time in the
documents filed by us with the Securities and Exchange Commission,
including our most recent Annual Report on Form 10-K and Quarterly Report
on Form 10-Q.
CONTACT - John R. Reaves, Chief Financial Officer, Natural Alternatives
International, Inc.,
760-736-7700 or investor@nai-online.com.
| |
SOURCE Natural Alternatives International, Inc.
 back to top
Related links:
http://www.nai-online.com
CONTACT:
John R. Reaves, Chief Financial Officer of
Natural Alternatives International, Inc., +1-760-736-7700,
investor@nai-online.com
| |
|
